Why routine clinical follow-up for patients with early stage endometrial cancer is not always necessary: A study on women in South Wales

International Journal of Gynecological Cancer

Volumn 24, Issue 3, 2014, Pages 556-563

  Aung, Lilly ^b   Howells, Robert E J ^a   Lim, Kenneth C K ^b   Hudson, Emma ^c   Jones, Peter W ^d  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^b ROYAL GWENT HOSPITAL   (United Kingdom)

^c VELINDRE CANCER CENTRE   (United Kingdom)

^d KEELE UNIVERSITY   (United Kingdom)

Author keywords

Follow up; Routine

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; ASYMPTOMATIC DISEASE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; EARLY CANCER; ENDOMETRIUM CANCER; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; SURVIVAL TIME; UNITED KINGDOM; CARCINOMA; ENDOMETRIAL NEOPLASMS; HEALTH SURVEY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; ENDOMETRIAL NEOPLASMS; FEMALE; GREAT BRITAIN; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POPULATION SURVEILLANCE; RETROSPECTIVE STUDIES;

EID: 84900434336     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0000000000000088     Document Type: Article

References (28)

1. National Cancer Survivorship Initiative (NCSI) Vision Document. Department of Health 2010.
2. Evans T, Sany O, Pearmain P, et al. Differential trends in the rising incidence of endometrial cancer by type: data from a UK population-based registry from 1994 to 2006. Br J Cancer. 2011;104:1505-1510.
3. Trovik J, Mauland KK, Werner HM, et al. Improved survival related to changes in endometrial cancer treatment, a 30-year population based perspective. Gynecol Oncol. 2012;125:381-387.
4. Gadducci A, Cosio S, Fanucchi A, et al. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer. Anticancer Res. 2000;20:1977-1984.
5. Salani R, Nagel CI, Drennen E, et al. Recurrence patterns and surveillance for patients with early stage endometrial cancer. Gynecol Oncol. 2011;123:205-207.
6. Fung-Kee-Fung M, Dodge J, Elit L, et al.; Cancer Care Ontario Program in Evidence-based Care Gynecology Cancer Disease Site Group. Follow-up after primary therapy for endometrial cancer: a systematic review. Gynecol Oncol. 2006;101:520-529.
7. Improving Outcomes in Gynaecological Cancer: the Research Evidence. Guidance on Commissioning Cancer Services. London, United Kingdom: Whetherby, NHS Executive, Department of Health; 2001:135-137.
8. Lewis RA, Neal RD, Hendry M, et al. Patients' and healthcare professionals' views of cancer follow-up: systematic review. Br J Gen Pract. 2009;59:e248-e259.
9. Kew FM, Galaal K, Manderville H, et al. Professionals' and patients' views of routine follow-up: a questionnaire survey. Int J Gynecol Cancer. 2007;17:557-560.
10. Kew FM, Galaal K, Manderville H. Patients' views of follow-up after treatment for gynaecological cancer. J Obstet Gynaecol. 2009;29:135-142.
11. Lim KC, Howells RE, Evans AS. The role of clinical follow up in early stage cervical cancer in South Wales. BJOG. 2004;111:1444-1448.
12. All Wales Guidelines for the Management of Gynaecological Cancers. Cancer Services Coordinating Group (CSCG). Cancer Services Office. NHS Cymru Wales 2001.
13. Shylasree TS, Howells RE, Lim K, et al.; All Wales Gynaecological Cancer Steering Group. Survival in ovarian cancer in Wales: Prior to introduction of all Wales guidelines. Int J Gynecol Cancer. 2006;16:1770-1776.
14. Sartori E, Pasinetti B, Chiudinelli F, et al. Surveillance procedures for patients treated for endometrial cancer: a review of the literature. Int J Gynecol Cancer. 2010;20:985-992.
15. Morice P, Levy-Piedbois C, Ajaj S, et al. Value and cost evaluation of routine follow-up for patients with clinical stage I/II endometrial cancer. Eur J Cancer. 2001;37:985-990.
16. Tjalma WA, van Dam PA, Makar AP, et al. The clinical value and the cost-effectiveness of follow-up in endometrial cancer patients. Int J Gynecol Cancer. 2004;14:931-937.
17. Bristow RE, Purinton SC, Santillan A, et al. Cost-effectiveness of routine vaginal cytology for endometrial cancer surveillance. Gynecol Oncol. 2006;103:709-713.
18. Salvesen HB, Akslen LA, Iversen T, et al. Recurrence of endometrial carcinoma and the value of routine follow up. Br J Obstet Gynaecol. 1997;104:1302-1307.
19. Shumsky AG, Stuart GC, Brasher PM, et al. An evaluation of routine follow-up of patients treated for endometrial carcinoma. Gynecol Oncol. 1994;55:229-233.
20. Jones JM, Ferguson S, Edwards E, et al. Experiences of care delivery: endometrial cancer survivors at end of treatment. Gynecol Oncol. 2012;124:458-464.
21. Ghazali N, Cadwallader E, Lowe D, et al. Fear of recurrence among head and neck cancer survivors: longitudinal trends. Psychooncology. 2013;22:807-813.
22. Zalewski K, Rzepka J, Madry R, et al. Analysis of risk factors for recurrence after treatment of endometrial uterine cancer [Article in Polish]. Ginekol Pol. 2009;80:687-693.
23. Reeves GK, Pirie K, Beral V, et al.; Million Women Study Collaboration. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ. 2007;335:1134.
24. Kimman ML, Voogd AC, Dirksen CD, et al. Improving the quality and efficiency of follow-up after curative treatment for breast cancerVrationale and study design of the MaCare trial. BMC Cancer. 2007;7:1.
25. Kimman ML, Dirksen CD, Voogd AC, et al. Economic evaluation of four follow-up strategies after curative treatment for breast cancer: results of an RCT. Eur J Cancer. 2011;47:1175-1185.
26. Kimman ML, Bloebaum MM, Dirksen CD, et al. Patient satisfaction with nurse-led telephone follow-up after curative treatment for breast cancer. BMC Cancer. 2010;10:174.
27. Kitchener H, Swart AM, Qian Q, et al.; ASTEC study group. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet. 2009;373:125-136.
28. Blake P, Swart AM, Orton J, et al.; ASTEC/EN.5 Study Group. Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis. Lancet. 2009;373:137-146.